You are here: Industry Insights > Pfizer

News List

EU secures 300 million doses of BioNTech, Pfizer’s COVID-19 vaccine pharmatimes
November 16, 2020
The European Commission has secured a supply deal with BioNTech and Pfizer for 300 million doses of their COVID-19 vaccine candidate.
European Commission approves contract with BioNTech-Pfizer alliance worldpharmanews
November 12, 2020
Yesterday, the European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further ...
Pfizer’s abrocitinib scores another phase III win in atopic dermatitis pharmatimes
November 12, 2020
Pfizer’s investigational oral Janus kinase 1 (JAK1) inhibitor abrocitinib has scored positive top-line results in a phase III atopic dermatitis trial.
Pfizer Initiates Study of Vupanorsen americanpharmaceuticalreview
November 12, 2020
Ionis Pharmaceuticals and its wholly owned subsidiary Akcea Therapeutics announced Pfizer has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in statin-treated patients with elevated non-high-density lipoprotein cholesterol (non-HDL-C) and ..
Pfizer, BioNTech to Supply 200M Doses of BNT162b2 to EU contractpharma
November 12, 2020
Deliveries are anticipated to start by the end of 2020, subject to clinical success and regulatory authorization.
Pfizer, BioNTech Announce COVID-19 Vaccine Demonstrates Efficacy in Phase 3 Analysis americanpharmaceuticalreview
November 11, 2020
Pfizer and BioNTech announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy ...
COVID-19 vaccine over 90 per cent effective: Pfizer expresspharma
November 10, 2020
Pfizer and BioNTech said they have so far found no serious safety concerns and expect to seek US authorisation this month for emergency use of the vaccine.
Pfizer, BioNTech COVID-19 Vax Candidate Successful in Phase III Interim Analysis contractpharma
November 10, 2020
mRNA-based vaccine candidate BNT162b2 found to be more than 90% effective in preventing COVID-19.
Financial Report; Pfizer contractpharma
November 06, 2020
Revenues down 4% in the quarter to $12.1 billion.
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen pharmaceutical-business-review
November 06, 2020
Ionis Pharmaceuticals and its wholly owned subsidiary Akcea Therapeutics, Inc., announced that Pfizer has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in statin-treated patients with elevated non-high-density lipoprotein cholesterol ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page